314 related articles for article (PubMed ID: 17076680)
21. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
[TBL] [Abstract][Full Text] [Related]
22. Influence of common mucosal co-factors on HIV infection in the female genital tract.
Ferreira VH; Kafka JK; Kaushic C
Am J Reprod Immunol; 2014 Jun; 71(6):543-54. PubMed ID: 24617528
[TBL] [Abstract][Full Text] [Related]
23. Microbicides for prevention of transmission of sexually transmitted diseases.
Howett MK; Kuhl JP
Curr Pharm Des; 2005; 11(29):3731-46. PubMed ID: 16305508
[TBL] [Abstract][Full Text] [Related]
24. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens.
Crowley-Nowick PA; Ellenberg JH; Vermund SH; Douglas SD; Holland CA; Moscicki AB
J Infect Dis; 2000 Mar; 181(3):939-45. PubMed ID: 10720516
[TBL] [Abstract][Full Text] [Related]
25. Microbicides for multidrug-resistant and multitropic HIV-1.
D'Cruz OJ; Uckun FM
Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
[TBL] [Abstract][Full Text] [Related]
26. Vaginal microbicides.
O'Brien RF
Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation.
Mauck CK
Sex Transm Dis; 2009 Mar; 36(3 Suppl):S73-5. PubMed ID: 19218892
[TBL] [Abstract][Full Text] [Related]
28. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses.
Kaushic C; Roth KL; Anipindi V; Xiu F
J Reprod Immunol; 2011 Mar; 88(2):204-9. PubMed ID: 21296427
[TBL] [Abstract][Full Text] [Related]
29. Topical microbicides: the time has come.
Dhawan D; Keller M; Klotman ME
AIDS Read; 2006 Mar; 16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed ID: 16538955
[TBL] [Abstract][Full Text] [Related]
30. Microbicides: a new frontier in HIV prevention.
McGowan I
Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303
[TBL] [Abstract][Full Text] [Related]
31. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
32. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.
Lindqvist M; Persson J; Thörn K; Harandi AM
J Immunol; 2009 May; 182(10):6435-43. PubMed ID: 19414797
[TBL] [Abstract][Full Text] [Related]
33. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
Madan RP; Keller MJ; Herold BC
Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
[TBL] [Abstract][Full Text] [Related]
34. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
35. Understanding factors that modulate HIV infection at the female genital tract mucosae for the rationale design of microbicides.
Saidi H; Jenabian MA; Belec L
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1485-97. PubMed ID: 22867060
[TBL] [Abstract][Full Text] [Related]
36. [Specific mucosal immunity in the female reproductive tract: protection against infectious diseases and regulation of fertility (part 2)].
Zivný J; Sterzl I
Ceska Gynekol; 2003 Jul; 68(4):254-8. PubMed ID: 14515648
[TBL] [Abstract][Full Text] [Related]
37. A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.
Patton DL; Cosgrove Sweeney YT; Paul KJ
Sex Transm Dis; 2008 Oct; 35(10):889-97. PubMed ID: 18607310
[TBL] [Abstract][Full Text] [Related]
38. Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases.
Herold BC; Bourne N; Marcellino D; Kirkpatrick R; Strauss DM; Zaneveld LJ; Waller DP; Anderson RA; Chany CJ; Barham BJ; Stanberry LR; Cooper MD
J Infect Dis; 2000 Feb; 181(2):770-3. PubMed ID: 10669374
[TBL] [Abstract][Full Text] [Related]
39. [Defenses of the female genital tract against infection].
Bélec L
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6 Suppl):4S45-4S59. PubMed ID: 12451358
[TBL] [Abstract][Full Text] [Related]
40. Council calls for guidance on spermicide use.
AIDS Alert; 1996 Mar; 11(3):27-30. PubMed ID: 11363240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
